These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24354479)

  • 1. Long-standing prophylactic therapy vs. episodic treatment in young people with severe haemophilia: a comparison of age-matched Danish and Russian patients.
    Ingerslev J; Lethagen S; Hvitfeldt Poulsen L; Sørensen B; Lopatina E; Tentsova I; Yastrubinetskaya O; Plyushch OP
    Haemophilia; 2014 Jan; 20(1):58-64. PubMed ID: 24354479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of haemophilic arthropathy in children: a Lithuanian--Danish comparative study.
    Saulyte Trakymiene S; Clausen N; Poulsen LH; Ingerslev J; Rageliene L
    Haemophilia; 2013 Mar; 19(2):212-8. PubMed ID: 23167920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.
    Fischer K; Valentino L; Ljung R; Blanchette V
    Haemophilia; 2008 Jul; 14 Suppl 3():196-201. PubMed ID: 18510542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study.
    Tagliaferri A; Feola G; Molinari AC; Santoro C; Rivolta GF; Cultrera DB; Gagliano F; Zanon E; Mancuso ME; Valdré L; Mameli L; Amoresano S; Mathew P; Coppola A;
    Thromb Haemost; 2015 Jul; 114(1):35-45. PubMed ID: 25855376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can long-term prophylaxis for severe haemophilia be stopped in adulthood? Results from Denmark and the Netherlands.
    van Dijk K; Fischer K; van der Bom JG; Scheibel E; Ingerslev J; van den Berg HM
    Br J Haematol; 2005 Jul; 130(1):107-12. PubMed ID: 15982352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VIII prophylaxis for adult patients with severe haemophilia A: results of a US survey of attitudes and practices.
    Walsh CE; Valentino LA
    Haemophilia; 2009 Sep; 15(5):1014-21. PubMed ID: 19493018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of primary and secondary prophylaxis on the clinical expression of joint damage in children with severe haemophilia A. Results of a multicenter non-concurrent cohort study.
    Schobess R; Kurnik K; Friedrichs F; Halimeh S; Krümpel A; Bidlingmaier C; Nowak-Göttl U
    Thromb Haemost; 2008 Jan; 99(1):71-6. PubMed ID: 18217137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-reported outcomes of 182 adults with severe haemophilia in Germany comparing prophylactic vs. on-demand replacement therapy.
    Mondorf W; Kalnins W; Klamroth R
    Haemophilia; 2013 Jul; 19(4):558-63. PubMed ID: 23560639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled, cross-sectional MRI evaluation of joint status in severe haemophilia A patients treated with prophylaxis vs. on demand.
    Oldenburg J; Zimmermann R; Katsarou O; Theodossiades G; Zanon E; Niemann B; Kellermann E; Lundin B;
    Haemophilia; 2015 Mar; 21(2):171-179. PubMed ID: 25470205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An objective method for assessing adherence to prophylaxis in adults with severe haemophilia.
    Ho S; Gue D; McIntosh K; Bucevska M; Yang M; Jackson S
    Haemophilia; 2014 Jan; 20(1):39-43. PubMed ID: 23919911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current status of prophylactic replacement therapy in children and adults with haemophilia.
    Ljung R; Gretenkort Andersson N
    Br J Haematol; 2015 Jun; 169(6):777-86. PubMed ID: 25819695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consequences of switching from prophylactic treatment to on-demand treatment in late teens and early adults with severe haemophilia A: the TEEN/TWEN study.
    Manco-Johnson MJ; Sanders J; Ewing N; Rodriguez N; Tarantino M; Humphries T;
    Haemophilia; 2013 Sep; 19(5):727-35. PubMed ID: 23750875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of traditional vs. Canadian tailored prophylaxis dosing of prophylactic factor infusions in children with haemophilia A and B in a single hemophilia treatment center.
    Dodd C; Watts RG
    Haemophilia; 2012 Jul; 18(4):561-7. PubMed ID: 22221939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy assessment of a new clotting factor concentrate in haemophilia A patients, including prophylactic treatment.
    Den Uijl I; Mauser-Bunschoten EP; Roosendaal G; Schutgens R; Fischer K
    Haemophilia; 2009 Nov; 15(6):1215-8. PubMed ID: 19686467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Personification of the standard treatment of patients with hemophilia A (results of a multicenter Russian open-labeled prospective study evaluating the use of haemoctin)].
    Zozulia NI; Pliushch OP
    Ter Arkh; 2010; 82(4):56-61. PubMed ID: 20481218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens.
    Berntorp E
    Haemophilia; 2009 Nov; 15(6):1219-27. PubMed ID: 19659939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
    Ahnström J; Berntorp E; Lindvall K; Björkman S
    Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials.
    Fischer K; Collins P; Björkman S; Blanchette V; Oh M; Fritsch S; Schroth P; Spotts G; Ewenstein B
    Haemophilia; 2011 May; 17(3):433-8. PubMed ID: 21299740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifelong prophylaxis in a large cohort of adult patients with severe haemophilia: a beneficial effect on orthopaedic outcome and quality of life.
    Khawaji M; Astermark J; Berntorp E
    Eur J Haematol; 2012 Apr; 88(4):329-35. PubMed ID: 22221195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic versus on-demand treatment strategies for severe haemophilia: a comparison of costs and long-term outcome.
    Fischer K; van der Bom JG; Molho P; Negrier C; Mauser-Bunschoten EP; Roosendaal G; De Kleijn P; Grobbee DE; van den Berg HM
    Haemophilia; 2002 Nov; 8(6):745-52. PubMed ID: 12410642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.